10th Sep 2018 16:08
LONDON (Alliance News) - Biotechnology company Shire PLC on Monday said two of its subsidiaries, Baxalta Inc and Shire Acquisitions Investments Ireland DAC, had received early offers for a majority of their senior notes.
Of the USD1.00 billion worth of 2.875% notes due 2022 issued by Baxalta, USD848.2 million have been tendered.
Also under the offer, USD399.8 million of Baxalta's USD500.0 million 3.6% senior notes due 2022, and USD1.35 billion of the USD1.75 billion 4.0% senior notes due 2025, were tendered.
Furthermore, USD711.7 million of the USD1.00 billion 5.25% Baxalta senior notes due 2045 were tendered.
In terms of Shire Acquisitions Investments Ireland, USD1.53 billion of its USD3.00 billion worth of 3.2% senior notes due 2026 were tendered.
Citigroup Global Markets Ltd and Morgan Stanley & Co LLC are acting as dealer managers for the tender offer with Global Bondholder Services Corp as depositary and information agent.
Shares in Shire were down 0.3% Monday afternoon at 4,271.50 pence each.
Related Shares:
Shire